Balance Sheet
Cash Flow Statement
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on SalesTimes Interest Earned

International Stem Cell (ISCO) Times Interest Earned (2016 - 2025)

Historic Times Interest Earned for International Stem Cell (ISCO) over the last 17 years, with Q3 2025 value amounting to $2.54.

  • International Stem Cell's Times Interest Earned rose 19879.88% to $2.54 in Q3 2025 from the same period last year, while for Sep 2025 it was $0.63, marking a year-over-year increase of 11613.5%. This contributed to the annual value of -$0.47 for FY2024, which is 9016.8% up from last year.
  • International Stem Cell's Times Interest Earned amounted to $2.54 in Q3 2025, which was up 19879.88% from $4.39 recorded in Q2 2025.
  • In the past 5 years, International Stem Cell's Times Interest Earned registered a high of $4.39 during Q2 2025, and its lowest value of -$34.61 during Q3 2021.
  • Over the past 5 years, International Stem Cell's median Times Interest Earned value was -$2.85 (recorded in 2023), while the average stood at -$5.02.
  • Within the past 5 years, the most significant YoY rise in International Stem Cell's Times Interest Earned was 20347.22% (2024), while the steepest drop was 900000.0% (2024).
  • Over the past 5 years, International Stem Cell's Times Interest Earned (Quarter) stood at -$7.88 in 2021, then soared by 123.46% to $1.85 in 2022, then tumbled by 774.64% to -$12.47 in 2023, then surged by 110.49% to $1.31 in 2024, then soared by 94.28% to $2.54 in 2025.
  • Its Times Interest Earned was $2.54 in Q3 2025, compared to $4.39 in Q2 2025 and -$5.24 in Q1 2025.